Fenella C Raymond from 2626 86Th St, Seattle, WA 98115, age 70, Phone: (206)5252429

view source

Location:

Seattle, WA

Industry:

Arts And Crafts

Work:

Seattle Biomedical Research Institute 2008 - 2009
Project Manager
ZymoGenetics, Inc. 1996 - 2008
Program Manager

Skills:

Clinical Trials
Biotechnology
Global Health
Project Management
Gcp
Lifesciences
Infectious Diseases

Fgf Homologs
view source
US Patent:

6352971, Mar 5, 2002
Filed:

Aug 5, 1999
Appl. No.:

09/368951
Inventors:

Theresa A. Deisher - Seattle WA
Darrell C. Conklin - Seattle WA
Fenella Raymond - Seattle WA
Thomas R. Bukowski - Seattle WA
Susan D. Holderman - Kirkland WA
Birgit Hansen - Seattle WA
Paul O. Sheppard - Redmond WA
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

A61K 3800
US Classification:

514 2, 435 71, 530350, 5303871, 4241921
Abstract:

The present invention relates to polynucleotide and polypeptide molecules for zFGF-5 a novel member of the FGF family. The polypeptides, and polynucleotides encoding them, are proliferative for muscle cells and may be used for remodelling cardiac tissue and improving cardiac function. The present invention also includes antibodies to the zFGF-5 polypeptides.

Nucleic Acid Which Encodes The Tumor Marker Zsig62
view source
US Patent:

6403783, Jun 11, 2002
Filed:

Jan 18, 2000
Appl. No.:

09/493565
Inventors:

Paul O. Sheppard - Granite Falls WA
Julia E. Novak - Bainbridge Island WA
Fenella Raymond - Seattle WA
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

C07H 2104
US Classification:

536 235, 536 231, 4353201, 435 691, 435325, 435348, 435349, 435410, 4352541, 4352542
Abstract:

Studies indicate that mutations in tumor suppressor genes occur early in the process of carcinogenesis, and that these mutations are correlated with a subsequent development of cancer. The detection of such alterations would provide useful molecular markers for diagnosis, surveillance, early tumor identification and intervention, and prognosis. A novel human gene, designated as âZsig62,â resides within a region of chromosome 16 that is associated with prostate and breast cancer, and that appears to contain tumor suppressor genes. Like a tumor suppressor gene, the Zsig62 gene is expressed in particular normal tissues, but not in tumors derived from those tissues.

Fgf Homologs
view source
US Patent:

6518236, Feb 11, 2003
Filed:

Jan 13, 1999
Appl. No.:

09/229947
Inventors:

Theresa A. Deisher - Seattle WA
Darrell C. Conklin - Seattle WA
Fenella Raymond - Seattle WA
Thomas R. Bukowski - Seattle WA
Susan D. Holderman - Seattle WA
Birgit Hansen - Seattle WA
Paul O. Sheppard - Redmond WA
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

C07K 1450
US Classification:

514 2, 514 12, 530350, 530399, 435 697
Abstract:

The present invention relates to polynucleotide and polypeptide molecules for zFGF5 a novel member of the FGF family. The polypeptides, and polynucleotides encoding them, are proliferative for muscle cells, in particular cardiac cells and may be used for remodeling cardiac tissue and improving cardiac function. The present invention also includes antibodies to the zFGF5 polypeptides.

Fgf Homolog Polypeptides
view source
US Patent:

7247608, Jul 24, 2007
Filed:

Oct 19, 2001
Appl. No.:

10/037922
Inventors:

Theresa A. Deisher - Seattle WA, US
Darrell C. Conklin - Seattle WA, US
Fenella Raymond - Seattle WA, US
Thomas R. Bukowski - Seattle WA, US
Susan D. Holderman - Kirkland WA, US
Birgit Hansen - Seattle WA, US
Paul O. Sheppard - Redmond WA, US
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

A61K 38/18
A61K 39/00
C07K 14/50
US Classification:

514 2, 530350, 5303871, 530300, 4241921
Abstract:

The present invention relates to polynucleotide and polypeptide molecules for zFGF-5 a novel member of the FGF family. The polypeptides, and polynucleotides encoding them, are proliferative for muscle cells and may be used for remodelling cardiac tissue and improving cardiac function. The present invention also includes antibodies to the zFGF-5 polypeptides.

Fgf Homologs And Antibodies Thereto
view source
US Patent:

7563438, Jul 21, 2009
Filed:

May 22, 2007
Appl. No.:

11/752197
Inventors:

Theresa A. Deisher - Seattle WA, US
Darrell C. Conklin - Seattle WA, US
Fenella C. Raymond - Seattle WA, US
Thomas R. Bukowski - Seattle WA, US
Susan D. Holderman - Seattle WA, US
Paul O. Sheppard - Redmond WA, US
Assignee:

ZymoGenetics, Inc. - Seattle WA
International Classification:

A61K 39/395
C07K 16/00
C07K 16/22
US Classification:

4241301, 4241391, 4241411, 4241581, 5303871, 5303879, 5303881, 53038824, 530402
Abstract:

The present invention relates to antibodies and fragments thereof, polynucleotide and polypeptide molecules for zFGF5 a novel member of the FGF family. The polypeptides, and polynucleotides encoding them, are proliferative for muscle cells, in particular cardiac cells and may be used for remodeling cardiac tissue and improving cardiac function. The present invention also includes antibodies to the zFGF5 polypeptides.

Mammalian Calcitonin-Like Polypeptide-1
view source
US Patent:

20020077467, Jun 20, 2002
Filed:

May 1, 2001
Appl. No.:

09/846573
Inventors:

Paul Sheppard - Granite Falls WA, US
Emma Moore - Seattle WA, US
Fenella Raymond - Seattle WA, US
Assignee:

ZymoGenetics, Inc.
International Classification:

C07H021/04
C07K014/705
C12P021/02
C12N005/06
US Classification:

536/023500, 530/350000, 435/320100, 435/325000, 435/069100
Abstract:

Novel mammalian calcitonin-like polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods including antibodies and anti-idiotypic antibodies.

Tumor Marker Zsig62
view source
US Patent:

20020197620, Dec 26, 2002
Filed:

Jan 28, 2002
Appl. No.:

10/058580
Inventors:

Paul Sheppard - Granite Falls WA, US
Julia Novak - Bainbridge Island WA, US
Fenella Raymond - Seattle WA, US
International Classification:

C12Q001/68
G01N033/574
C07H021/04
C12N009/00
C12P021/02
C12N005/06
C07K016/30
US Classification:

435/006000, 435/007230, 435/183000, 435/320100, 435/325000, 536/023200, 530/388800
Abstract:

Studies indicate that mutations in tumor suppressor genes occur early in the process of carcinogenesis, and that these mutations are correlated with a subsequent development of cancer. The detection of such alterations would provide useful molecular markers for diagnosis, surveillance, early tumor identification and intervention, and prognosis. A novel human gene, designated as “Zsig62,” resides within a region of chromosome 16q that is associated with prostate and breast cancer, and that appears to contain tumor suppressor genes. Like a tumor suppressor gene, the Zsig62 gene is expressed in particular normal tissues, but not in tumors derived from those tissues.

Novel Fgf Homologs
view source
US Patent:

20030008351, Jan 9, 2003
Filed:

Feb 21, 2002
Appl. No.:

10/081347
Inventors:

Theresa Deisher - Seattle WA, US
Darrell Conklin - Seattle WA, US
Fenella Raymond - Seattle WA, US
Thomas Bukowski - Seattle WA, US
Susan Holderman - Seattle WA, US
Paul Sheppard - Redmond WA, US
Assignee:

ZymoGenetics, Inc.
International Classification:

C07K017/00
C07K014/00
C07K001/00
C12N005/02
C12N005/00
C12N015/74
C12N015/70
C12N015/63
C12N015/00
C12N015/09
C12P021/06
C07H021/04
A61K038/00
US Classification:

435/069100, 435/325000, 435/320100, 514/012000, 530/350000, 536/023500
Abstract:

The present invention relates to polynucleotide and polypeptide molecules for ZFGF5 a novel member of the FGF family. The polypeptides, and polynucleotides encoding them, are proliferative for muscle cells, in particular cardiac cells and may be used for remodeling cardiac tissue and improving cardiac function. The present invention also includes antibodies to the zFGF5 polypeptides.